Overcoming the Challenges in the Development of Pricing Analogues for Diseases with No Current Standard of Care
Time: 2:00 pm
day: Conference Day One
Details:
- Understanding how small pricing deviations in rare diseases can significantly impact the overall business case, emphasizing the need for precise pricing assumptions
- Identifying relevant proxy indications and market data to build a pricing framework in the absence of a direct comparator
- Collaborating with key stakeholders, including payers and clinicians, to establish a valuebased rationale for pricing in uncharted disease areas
